Who makes [68Ga]Ga-OncoCAIX?

[68Ga]Ga-OncoCAIX is developed by Philogen S.p.A..

What development phase is [68Ga]Ga-OncoCAIX in?

[68Ga]Ga-OncoCAIX is in Phase 1.

Last reviewed 2026-04-20 · How we verify

[68Ga]Ga-OncoCAIX

Philogen S.p.A. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	[68Ga]Ga-OncoCAIX
Sponsor	Philogen S.p.A.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[68Ga]Ga-OncoCAIX CI brief — competitive landscape report
[68Ga]Ga-OncoCAIX updates RSS · CI watch RSS
Philogen S.p.A. portfolio CI